跳至主要内容
临床试验/EUCTR2011-000739-97-AT
EUCTR2011-000739-97-AT进行中(未招募)1 期

Prospective, randomized, controlled, open-label study evaluating quality of life in patients with advanced malignant tumors with and without add-on” homeopathy - HIC

Med. Univ. Wien0 个研究点目标入组 150 人开始时间: 2011年4月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Diagnosis of glioblastoma IV, non small cell lung carcinoma IV and metastasized sarcoma within the last 8 weeks.
  • •Patients aged over 18 years
  • •signed informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years)
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •intake of homeopathic remedies except the prescribed ones;
  • •refusal of intake of the prescribed homeopathic remedies

研究者

发起方
Med. Univ. Wien

相似试验

Homeopathy in advanced malignant tumors | 临床试验